This research was conducted in a fashion similar to Goswami et al. [23] who reported on Se-Transferrin against leukemia cell lines and Khandelwal et al. for their comparison of Se-Herceptin®, and Avastin® against Triple Negative Breast Cancer (TNBC) cell lines [24]. This evidence concerns the gene TF and leukemia.